Drug Approval Package

NovoLog Mix 70/30 (70% Insulin Aspart [rDNA Origin] Protamine Suspension and 30% Insulin Aspart [rDNA Origin]) Injection)
Company:  Novo Nordisk Pharmaceuticals, Inc.
Application No.:  21-172
Approval Date: 11/1/2001

• Approval Letter(s) (PDF)  

• Printed Labeling (PDF)  

• Medical Review(s)
  Part 1 (PDF)  
  Part 2 (PDF)  

• Chemistry Review(s) (PDF)  

• Pharmacology Review(s) (PDF)  

• Microbiology Review(s) (PDF)   

• Clinical Pharmacology Biopharmaceutics Review(s) (PDF)  

• Administrative Document(s) (PDF)  

• Correspondence 
  Part 1 (PDF)  
  Part 2 (PDF)

Date created: August 29, 2002

Back to Top    Drugs@FDA

Note: Documents in PDF format require the Adobe Acrobat Reader®.